Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial … – MarketWatch (press release)

Pharmaxis Receives J-Code For ARIDOL® (Mannitol Inhalation Powder) Bronchial
MarketWatch (press release)
ARIDOL should not be used as a stand alone test to assess asthma or as a screening test for asthma, but as part of a physician's overall assessment of asthma. The new J-code becomes effective on January 1, 2012. J-codes are used by providers to bill

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.